Free Trial

Curated Wealth Partners LLC Makes New $993,000 Investment in Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Curated Wealth Partners LLC acquired a new position in Colgate-Palmolive (NYSE:CL - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 10,596 shares of the company's stock, valued at approximately $993,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Brighton Jones LLC raised its stake in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after purchasing an additional 450 shares during the period. Bernard Wealth Management Corp. bought a new stake in Colgate-Palmolive during the 4th quarter worth approximately $36,000. Apollon Wealth Management LLC lifted its stake in Colgate-Palmolive by 12.2% in the 4th quarter. Apollon Wealth Management LLC now owns 25,317 shares of the company's stock worth $2,302,000 after purchasing an additional 2,746 shares in the last quarter. Kingsview Wealth Management LLC boosted its holdings in Colgate-Palmolive by 133.9% in the 4th quarter. Kingsview Wealth Management LLC now owns 36,120 shares of the company's stock valued at $3,284,000 after purchasing an additional 20,676 shares during the period. Finally, Thompson Investment Management Inc. grew its position in shares of Colgate-Palmolive by 19.7% during the 4th quarter. Thompson Investment Management Inc. now owns 3,645 shares of the company's stock valued at $331,000 after purchasing an additional 600 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CL has been the topic of a number of recent analyst reports. Citigroup increased their price objective on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Barclays lowered their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, April 11th. UBS Group upped their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research report on Thursday, April 17th. JPMorgan Chase & Co. boosted their price target on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. Finally, Wells Fargo & Company boosted their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research report on Wednesday, April 2nd. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $102.12.

View Our Latest Analysis on CL

Colgate-Palmolive Trading Up 0.1%

Shares of CL traded up $0.08 during trading hours on Wednesday, reaching $92.02. 5,353,809 shares of the company traded hands, compared to its average volume of 4,740,439. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The company's fifty day moving average price is $91.63 and its two-hundred day moving average price is $91.13. The company has a market capitalization of $74.57 billion, a price-to-earnings ratio of 26.14, a price-to-earnings-growth ratio of 4.20 and a beta of 0.38.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The business had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. During the same period in the previous year, the firm posted $0.86 EPS. The business's revenue was down 3.0% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Thursday, April 17th were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.26%. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Thursday, April 17th. Colgate-Palmolive's dividend payout ratio is presently 58.76%.

Colgate-Palmolive announced that its Board of Directors has approved a share buyback plan on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 6.8% of its stock through open market purchases. Stock buyback plans are often an indication that the company's management believes its stock is undervalued.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines